🔍Welcome back to Part 2 of our dialogue with Skin and Joint Podcast EADV Ambassador, Dr.Melinda Gooderham, where we delve deep into the groundbreaking advancements in treating chronic hand eczema, featuring the innovative pivotal trials and their implications for care. Are we entering a new era for care for our patients with chronic hand eczema? Making her guest hosting debut on the Podcast, Dr. Jessica Asgarpour joins us for PART 2. 🆕Key Highlights we take a look at in PART 2: Exploring New Agents in Chronic Hand Eczema Treatment (Efficacy Perspectives and Quality of Life Measures): Dr. Gooderham offers an in-depth analysis of delgocitinib cream, a new topical for CHE. Delta 1 and Delta 2 trials focus on efficacy and safety Outcomes in terms of the Hand Eczema Area and Severity Index (HEXI) and DLQI scores. Safety Profile of Topical JAK inhibitors: Patient Adherence and Formulation Challenges The role of delgocitinib as a non-steroidal option in treating hand eczema. Discussion on the evolving landscape of dermatological treatments and patient access to new therapies Episode supported by an IME Grant from LEO Pharma ABOUT Dr.Melinda Gooderham, MD, FRCPC ( Dermatology) Toronto, ON Melinda Gooderham MD MSc FRCPC Dr. Gooderham is a Dermatologist and Medical Director at the SKiN Centre for Dermatology and an Investigator with Probity Medical Research. She is an Assistant Professor at Queens University and a Consultant Physician at the Peterborough Regional Health Centre. She is a fellow of the Royal College of Physicians and Surgeons of Canada. Dr. Gooderham has been the principal investigator for over 200 clinical trials and she practices with a focus on inflammatory diseases of the skin. She also contributes to several peer-reviewed dermatology publications as an associate editor, reviewer, and has been an author of 205 articles. She enjoys lecturing to global audiences on new therapies for skin diseases. About Dr.Jessica Asgarpour, MD, FRCPC Dermatologist | Toronto Dr. Jessica Asgarpour is a Canadian and American board-certified dermatologist. She completed her medical school at the Cumming School of Medicine, in Calgary, Alberta, where she was born and raised. She went on to the University of Alberta for her residency training in dermatology, where she acted as co-chief resident from 2019-2020, and was awarded the Dr. Andrew Lin Dermatology Scholar award. She has also been awarded multiple scholarships to conferences to keep her up-to-date with the ever changing medical literature. She has published in many peer-reviewed journals, and practices medicine with this same evidence-based approach. She practices medical, surgical and cosmetic dermatology. When she is not practicing dermatology, she enjoys keeping active and loves to run, spin and hike. 📻www.skinandjoints.ca ✉️info@skinandjoints.ca
🔍Welcome back to Part 2 of our dialogue with Skin and Joint Podcast EADV Ambassador, Dr.Melinda Gooderham, where we delve deep into the groundbreaking advancements in treating chronic hand eczema, featuring the innovative pivotal trials and their implications for care.Â
Are we entering a new era for care for our patients with chronic  hand eczema?
Making her guest hosting debut on the Podcast, Dr. Jessica Asgarpour joins us for PART 2.
Â
🆕Key Highlights we take a look at in PART 2:
Exploring New Agents in Chronic Hand Eczema Treatment (Efficacy Perspectives and Quality of Life Measures):
 Safety Profile of Topical  JAK inhibitors:
Episode supported by an IME Grant from LEO Pharma
Â
ABOUT Dr.Melinda Gooderham, MD, FRCPC ( Dermatology)
Toronto, ON
Melinda Gooderham MD MSc FRCPC Dr. Gooderham is a Dermatologist and Medical Director at the SKiN Centre for Dermatology and an Investigator with Probity Medical Research. She is an Assistant Professor at Queens University and a Consultant Physician at the Peterborough Regional Health Centre. She is a fellow of the Royal College of Physicians and Surgeons of Canada.
Dr. Gooderham has been the principal investigator for over 200 clinical trials and she practices with a focus on inflammatory diseases of the skin. She also contributes to several peer-reviewed dermatology publications as an associate editor, reviewer, and has been an author of 205 articles. She enjoys lecturing to global audiences on new therapies for skin diseases.
Â
Dr. Jessica Asgarpour is a Canadian and American board-certified dermatologist. She completed her medical school at the Cumming School of Medicine, in Calgary, Alberta, where she was born and raised. She went on to the University of Alberta for her residency training in dermatology, where she acted as co-chief resident from 2019-2020, and was awarded the Dr. Andrew Lin Dermatology Scholar award. She has also been awarded multiple scholarships to conferences to keep her up-to-date with the ever changing medical literature.Â
She has published in many peer-reviewed journals, and practices medicine with this same evidence-based approach. She practices medical, surgical and cosmetic dermatology. When she is not practicing dermatology, she enjoys keeping active and loves to run, spin and hike. Â
Â
Â
đź“»www.skinandjoints.ca
✉️info@skinandjoints.ca
Â
Â